SCIENCE IN THE NEWS DAILY
Herceptin Brings New Age in Breast Cancer Care
from USA Today
Barbara Bradfield has lived to see dramatic changes in breast cancer. When she was diagnosed in 1989, Bradfield's tumor—which produced an overabundance of a protein called HER2—was considered especially deadly. Today, women with tumors like hers have some of the best survival rates in breast cancer.
Experts say the drug that has kept Bradfield healthy for so long, Herceptin, has changed the nature of breast cancer and helped doctors better understand what causes the disease.
In the 10 years since it was approved, doctors say Herceptin also has encouraged the development of a growing arsenal of new therapies that target cancer cells but spare patients from many of the grueling side effects of traditional chemotherapy. Bradfield, who received chemo before and during her Herceptin therapy, developed permanent hearing loss and numbness in her fingers because of those older drugs.
Read more...
Click here to listen to podcasts of American Scientist Pizza Lunches, informal lectures where scientists present new research to non-scientists. Originally intended for science communicators in the Research Triangle Park region of North Carolina, the audio slideshows are now available to anyone online. New talks are posted periodically during the academic year.
Science in the Media
Newspapers:
Magazines and Web Sites:
The Science-Media Intersection:
Subscribe to Our Content!
Visit our RSS Feeds page to choose among 13 customized feeds, or create a free My AmSci account to request an email notice whenever a specified author, department or discipline appears online.